Interferon regulatory factors: critical mediators of human lupus
- PMID: 25445206
- PMCID: PMC4306637
- DOI: 10.1016/j.trsl.2014.10.002
Interferon regulatory factors: critical mediators of human lupus
Abstract
The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial, and the interferon regulatory factors (IRFs) play an important role. Autoantibodies formed in SLE target nuclear antigens, and immune complexes formed by these antibodies contain nucleic acid. These immune complexes can activate antiviral pattern recognition receptors (PRRs), resulting in the downstream activation of IRFs, which can induce type I interferon (IFN-I) and other inflammatory mediators. Genetic variations in IRFs have been associated with susceptibility to SLE, and current evidence supports the idea that these polymorphisms are gain of function in humans. Recent studies suggest that these genetic variations contribute to the break in humoral tolerance that allows for nucleic acid binding autoantibodies, and that the same polymorphisms also augment IFN-I production in the presence of these autoantibody immune complexes, forming a feed-forward loop. In this review, we will outline major features of the PRR/IRF systems and describe the role of the IRFs in human SLE pathogenesis.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Interferon regulatory factors in human lupus pathogenesis.Transl Res. 2011 Jun;157(6):326-31. doi: 10.1016/j.trsl.2011.01.006. Epub 2011 Feb 8. Transl Res. 2011. PMID: 21575916 Free PMC article. Review.
-
A compass that points to lupus: genetic studies on type I interferon pathway.Genes Immun. 2007 Sep;8(6):445-55. doi: 10.1038/sj.gene.6364409. Epub 2007 Jun 21. Genes Immun. 2007. PMID: 17581625 Review.
-
Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.Clin Dev Immunol. 2012;2012:780436. doi: 10.1155/2012/780436. Epub 2012 Nov 1. Clin Dev Immunol. 2012. PMID: 23251221 Free PMC article. Review.
-
Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production.J Immunol. 2007 Jun 1;178(11):6876-85. doi: 10.4049/jimmunol.178.11.6876. J Immunol. 2007. PMID: 17513736
-
[Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Dec 18;48(6):1100-1104. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 27987522 Review. Chinese.
Cited by
-
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):365-380. doi: 10.31138/mjr.270324.tis. eCollection 2024 Jun. Mediterr J Rheumatol. 2024. PMID: 39193187 Free PMC article. Review.
-
Emerging roles of circular RNAs in systemic lupus erythematosus.Mol Ther Nucleic Acids. 2021 Mar 1;24:212-222. doi: 10.1016/j.omtn.2021.02.028. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33767917 Free PMC article. Review.
-
Type I Interferons in Autoimmunity.J Invest Dermatol. 2022 Mar;142(3 Pt B):793-803. doi: 10.1016/j.jid.2021.11.031. Epub 2022 Jan 10. J Invest Dermatol. 2022. PMID: 35016780 Free PMC article. Review.
-
Interferon regulatory factor signaling in autoimmune disease.Cytokine. 2017 Oct;98:15-26. doi: 10.1016/j.cyto.2017.02.006. Epub 2017 Mar 7. Cytokine. 2017. PMID: 28283223 Free PMC article. Review.
-
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.Trends Mol Med. 2021 Feb;27(2):152-171. doi: 10.1016/j.molmed.2020.09.009. Epub 2020 Oct 9. Trends Mol Med. 2021. PMID: 33046407 Free PMC article. Review.
References
-
- Goldblatt F, O’Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382:797–808. - PubMed
-
- Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 1998;7:113–118. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical